Dr. John Reed, president and CEO of The Burnham Institute, was appointed to the Independent Citizen's Oversight Committee that will govern the California Institute for Regenerative Medicine created last month.

Just as SSTI and other post-election analysts predicted, California’s recent passage of a $3 billion commitment to stem cell research is triggering responses from across the country. Wisconsin is the first to outline a specific, strategic reaction to the California referendum in an effort to retain or regain momentum in the race to encourage bio-based economic growth.

Using data from its 2004 Best Performing Cities Index, Milken has generated a comprehensive table ranking cities by one- and five-year measurements of job growth, wages and salaries, and relative high tech gross domestic product (GDP) growth, and other measurements.

What policies, investments and programs would be most effective for communities trying to attract, retain or build a local pharmaceutical industry? Research parks? Tax incentives? Biotech seed capital funds?

Duane Roth is the new executive director of UCSD CONNECT. Roth was CEO of Alliance Pharmaceuticals in San Diego.

While the National Institutes of Health (NIH) and the National Science Foundation (NSF) have voiced caution and funded efforts to understand the potential societal and environmental implications of nanotechnology deployment, both agencies announced much larger funding commitments - totaling $213 million - to expedite commercial applications for the explosive field.

Nanotech Solutions for Cancer

More than half since recession "officially" ended

There is little comforting news in a new statistical report for workers in the U.S. information and communication technologies (ICT) sector. Researchers from the University of Illinois-Chicago found the sector lost 403,300 jobs between March 2001 and April 2004.

As part of a new initiative to address pressing ethical, legal and social questions raised by recent advances in genetic and genomic research, the National Human Genome Research Institute (NHGRI) has awarded approximately $20 million in grants to fund interdisciplinary centers within universities around the country over the next five years. NHGRI is one of the National Institutes of Health (NIH).

New York City Launches Second Biotech Incubator Companies wanting to commercialize new technologies can now bring their companies to Brooklyn, with the June opening of a new technology incubator located near Downstate University's biochemistry department.

Former New Mexico Gov. Garrey Carruthers (1987-1990) has been named vice provost for economic development at New Mexico State University.

Does it matter whether a start-up takes money from a large venture firm or a small venture firm? According to the just-released VentureOne Deal Terms Report, the answer is a resounding yes.

The Association of University Research Parks has recognized Sandia National Laboratories for the 2003 Excellence in Technology Transfer Award. Over the past five years, Sandia has participated in 183 new cooperative research and development agreements with industry partners to jointly develop technology that is incorporated into commercial products.

The University of California, San Diego's CONNECT program will begin a search for a new director since Fred Cutler's resignation at the end of September.

Randy Burge has announced his resignation as director of the New Mexico Department of Economic Development's Office of Science and Technology. Mike Orshan will serve as acting director beginning Sept. 29.

In signing his state's fiscal year 2003-04 budget on August 2, California Governor Gray Davis shaved General Fund expenditures by $7 billion in an effort to address a $38.2 billion budget shortfall. Among those cuts was funding for the California Technology, Trade and Commerce Agency (TTCA), the state's principal catalyst for innovation, investment and economic opportunity.

California

Richard Murphy was named interim president of the California Institute of Regenerative Medicine (CIRM). Arlene Chiu announced she will resign as interim chief scientific officer of CIRM, effective Oct. 31.